Novastem

What Novastem does

Novastem is a regenerative medicine clinic headquartered in Tijuana, Mexico, founded in 2014, that administers autologous and allogeneic stem cell-based therapies to individual patients across neurological, musculoskeletal, cardiorespiratory, and wellness indications. The clinic operates from a state-of-the-art Tijuana facility positioned minutes from the US-Mexico border, with formal US mailing addresses in San Ysidro, California used for patient communications and medical records exchange. Treatment volume is driven by inbound individual patients, predominantly US medical tourism clients seeking therapies that are not yet approved domestically, supplemented by a base of recurring bioidentical hormone replacement therapy (BHRT) subscribers.

The company's core technology stack centers on mesenchymal stem cells (MSCs) sourced from bone marrow, Wharton's Jelly (umbilical cord tissue), and adipose tissue, combined with platelet-rich plasma (PRP) and exosomes, administered via intravenous, inhalation, intrathecal, intracavernous, and ultrasound- or fluoroscopy-guided injection delivery. Stem cells are sourced from FDA-cGMP licensed manufacturers under a core supply partnership with Stemedica, with strict acceptance protocols and laboratory studies conducted before each therapy. Treatment delivery is supported by three FDA- and Mexico-registered clinical trial protocols covering Knee Osteoarthritis, Chronic Musculoskeletal Pain, and Spinal Cord Injury, and is overseen by a medical team holding seven medical licenses and eight board certifications.

Novastem operates a sales-led direct-to-patient go-to-market motion. Patients submit applications for treatment evaluation, receive personalized treatment plans, and schedule appointments at the Tijuana facility; an in-person 45-minute consultation is priced at $65 USD and a 30-minute telemedicine consultation at $55 USD, both credited toward total treatment cost. Marketing is conducted through an educational blog with peer-reviewed citations, organic social channels (Facebook, Instagram, YouTube), and an email newsletter. Named individual customers include Rachna Kumar, Adria Nava, Mike Jacobsen, and a high-visibility stroke recovery case involving hockey legend Gordie Howe. The company is privately held, with no disclosed funding rounds, ownership structure, or revenue figures.

Name

Novastem

Legal name

Novastem

Website

https://novastem.com

Company type

Private

Founded year

2014

Operating status

Operating

Headcount range

11–50 employees

Short description

Novastem is a Tijuana, Mexico-based regenerative medicine clinic founded in 2014 that administers stem cell therapies sourced from cGMP-certified manufacturers to individual patients across neurological, musculoskeletal, cardiorespiratory, and wellness indications, primarily serving US medical tourism clients.

Ownership category

akta.pro rank

Product category

Regenerative Medicine

NAICS

Research and Development in Biotechnology (except Nanobiotechnology) (541714)

SIC

Services-Specialty Outpatient Facilities, Nec (8093), Services-Health Services (8000)

akta.pro primary industry

Stem Cell–Based Regenerative Therapies (HLAAAGAA)

akta.pro secondary industry

Stem Cell Therapies (MSC/iPSC/HSC-derived) (HLAAABAE)

Keywords

• Stem cell therapy
• Regenerative medicine
• Orthopedic treatments
• Neurological therapy
• Bioidentical hormones

Headquarters

HQ city

San Ysidro

HQ country

United States

HQ region

North America

Offices3 records

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Operations, Supply Chain, Technology or R&D, Marketing or Sales, Infrastructure

Revenue model

1. Consultation Fees: In-person consultation at $65 USD for 45 minutes and telemedicine consultation at $55 USD for 30 minutes. Consultation fees are credited toward total treatment cost.
2. Stem Cell Therapy Treatments: Revenue generated from stem cell therapy procedures for various conditions including neurological, musculoskeletal, cardiorespiratory, and wellness treatments. Costs depend on the type of therapy and number of sessions required after consultation.
3. BHRT (Bioidentical Hormone Replacement Therapy): Hormone replacement therapy using bioidentical hormones delivered via pills, patches, creams, gels, or injections.

Pricing tiers

Go-to-market motion1 record

Distribution channels2 records

Marketing channels5 records

Core offering

Novastem is a regenerative medicine center offering stem cell therapies using mesenchymal stem cells (MSCs) derived from bone marrow, Wharton's Jelly (umbilical cord tissue), and adipose tissue, combined with platelet-rich plasma (PRP) and exosomes. The clinic provides treatments for neurological, musculoskeletal, cardiorespiratory, and wellness conditions, administered through intravenous, inhalation, intrathecal, intracavernous, and ultrasound-guided injection methods at its Tijuana, Mexico facility.

Product overview

Novastem is a regenerative medicine center offering stem cell therapies and treatments. The core offering is stem cell-based regenerative medicine utilizing mesenchymal stem cells (MSCs) derived from bone marrow, adipose tissue, and Wharton's Jelly, along with neural stem cells and platelet-rich plasma. Treatments span four main categories: Neurological (stroke, multiple sclerosis, TBI), Musculoskeletal (spine, shoulder, knee conditions), Cardiorespiratory (heart failure, asthma, post-COVID), and Wellness (erectile dysfunction, hormone replacement, hair restoration). The company also maintains a research portfolio covering pharmacy innovations, AI applications, and drug development. All treatments are administered at their Tijuana, Mexico facility with oversight by board-certified physicians and scientists.

Differentiator

Problem solved

Functional benefit

Products and services

• Neurological Stem Cell Therapy Stem cell therapy for neurological conditions including stroke, multiple sclerosis, traumatic brain injury, cerebral palsy, and early-onset Parkinson's, ALS, and Alzheimer's, utilizing mesenchymal and neural stem cells to promote neural repair and function recovery.
• Musculoskeletal Stem Cell Therapy Stem cell therapy for musculoskeletal conditions affecting the spine, shoulder, knee, hip, ankle, and other joints, using bone marrow-derived mesenchymal stem cells combined with platelet-rich plasma for tissue repair and regeneration in osteoarthritis, sports injuries, cartilage damage, and chronic pain.
• Cardiorespiratory Stem Cell Therapy Stem cell therapy for cardiorespiratory conditions including heart failure, asthma, COPD, ARDS, cystic fibrosis, and post-COVID sequelae, using mesenchymal stem cells administered intravenously or via inhalation for anti-inflammatory and tissue repair effects.
• Wellness and Sexual Health Stem Cell Therapy Regenerative wellness treatments including erectile dysfunction therapy using bone marrow-derived stem cells (70% success rate) and hair restoration using adipose-derived stem cells combined with PRP for anti-aging and longevity applications.
• Bioidentical Hormone Replacement Therapy Hormone replacement therapy using bioidentical hormones delivered via pills, patches, creams, gels, or injections for patients experiencing menopause, andropause, or hormonal imbalances.
• Consultation Services In-person consultation ($65 USD for 45 minutes) and telemedicine consultation ($55 USD for 30 minutes) with medical evaluation and personalized treatment planning. Consultation fees are credited toward total treatment cost.

Quantifiable outcome

• 70% success rate in treating erectile dysfunction, including post-prostatectomy patients
• +2 more outcomes

Named customers4 records

Segments7 records

Ideal customer profiles7 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature4 records

Partnerships

One partnership is on record.

• StemedicacoreTechnology or IntegrationNovastem sources bone marrow derived mesenchymal stem cells and neural stem cells from Stemedica cGMP facilities in the US for their neurological treatments including stroke and TBI therapies.

Scale indicators4 records

Recent moves6 records

Expansion highlights6 records

Broad incumbents

• Regenexx: Larger US-based regenerative medicine network offering stem cell and PRP therapies for orthopedic conditions. Comparable core therapies (BMAC, PRP) but operates under stricter US regulatory framework.
• Cleveland Clinic Cell Therapy: Major US medical center with cell therapy and regenerative medicine programs for orthopedic and neurological indications. Comparable therapeutic areas but at vastly larger institutional scale.
• Mayo Clinic Regenerative Medicine: Academic medical center with established regenerative medicine and stem cell therapy programs. Comparable treatment categories but operates within rigorous US clinical research framework.

Direct peers

• BioXcellerator: Stem cell therapy clinic treating orthopedic, neurological, and autoimmune conditions using MSCs and exosomes. Directly comparable treatment portfolio and international patient model.
• StemGenex: US-based stem cell clinic offering autologous MSC therapies for neurological and inflammatory conditions. Closely comparable service offering though operating under US jurisdiction.
• R3 Stem Cell: Network of regenerative medicine clinics offering stem cell and exosome therapies for a wide range of conditions. Comparable horizontal segmentation across multiple therapeutic indications.
• Celltex Therapeutics: Mexico-based stem cell therapy company offering autologous MSC therapies for similar orthopedic, neurological, and wellness indications. Closely comparable business model, geography, and treatment portfolio to Novastem.
• GARM Clinic: Regenerative medicine clinic in Mexico providing stem cell therapies for orthopedic, neurological, and autoimmune conditions. Directly comparable patient acquisition model targeting US patients.
• Stemaid Institute: Stem cell clinic operating in Mexico offering MSC and exosome therapies for chronic and degenerative conditions. Comparable cross-border, indication-broad regenerative medicine model.

Others

• Stemedica Cell Technologies: Novastem's upstream cell supplier and strategic partner. Comparable in biotechnology platform but operates as a manufacturer rather than clinical service provider.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

• YouTubeyoutube.com/@novastem
• Facebookfacebook.com/novastem
• Instagraminstagram.com/novastem
• LinkedInlinkedin.com/company/novastem

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Novastem